Over 200 interstitial lung diseases, from ultra rare to relatively common, are recognised.
Most interstitial lung diseases are characterised by inflammation or fibrosis within the …

Rationale: Workplace inhalational hazards remain common worldwide, even though they
are ameliorable. Previous American Thoracic Society documents have assessed the …

Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It
represents a collaborative effort among the American Thoracic Society, Japanese …

Background: This document provides clinical recommendations for the diagnosis of
idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American …

Background The purpose of this analysis is to provide evidence-based and consensus-
derived guidance for clinicians to improve individual diagnostic decision-making for …

Awareness of hypersensitivity pneumonitis (HP) as a unique disease entity dates back to the
18th century (1). Since then, numerous inciting agents have been attributed to inducing HP …

There are limited epidemiologic studies describing the global burden and geographic
heterogeneity of interstitial lung disease (ILD) subtypes. We found that among seventeen …

Hypersensitivity pneumonitis (HP) is a complex syndrome caused by the inhalation of a
variety of antigens in susceptible and sensitized individuals. These antigens are found in the …

Accurately diagnosing fibrotic interstitial lung disease (ILD) is a challenge even for expert
clinicians. It requires multidisciplinary integration of clinical, radiological, and pathological …

Hypersensitivity pneumonitis (HP) is an immune-mediated disease triggered by a large
variety of organic and nonorganic materials (“inducers”) in susceptible individuals. The …